1. Home
  2. TWI vs ALLO Comparison

TWI vs ALLO Comparison

Compare TWI & ALLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TWI
  • ALLO
  • Stock Information
  • Founded
  • TWI 1890
  • ALLO 2017
  • Country
  • TWI United States
  • ALLO United States
  • Employees
  • TWI N/A
  • ALLO N/A
  • Industry
  • TWI Steel/Iron Ore
  • ALLO Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • TWI Industrials
  • ALLO Health Care
  • Exchange
  • TWI Nasdaq
  • ALLO Nasdaq
  • Market Cap
  • TWI 480.2M
  • ALLO 431.9M
  • IPO Year
  • TWI 1993
  • ALLO 2018
  • Fundamental
  • Price
  • TWI $6.95
  • ALLO $1.87
  • Analyst Decision
  • TWI Strong Buy
  • ALLO Buy
  • Analyst Count
  • TWI 1
  • ALLO 12
  • Target Price
  • TWI $11.00
  • ALLO $10.06
  • AVG Volume (30 Days)
  • TWI 1.2M
  • ALLO 2.7M
  • Earning Date
  • TWI 10-30-2024
  • ALLO 11-07-2024
  • Dividend Yield
  • TWI N/A
  • ALLO N/A
  • EPS Growth
  • TWI N/A
  • ALLO N/A
  • EPS
  • TWI N/A
  • ALLO N/A
  • Revenue
  • TWI $1,852,563,000.00
  • ALLO $43,000.00
  • Revenue This Year
  • TWI $3.14
  • ALLO N/A
  • Revenue Next Year
  • TWI N/A
  • ALLO N/A
  • P/E Ratio
  • TWI N/A
  • ALLO N/A
  • Revenue Growth
  • TWI N/A
  • ALLO 26.47
  • 52 Week Low
  • TWI $6.34
  • ALLO $1.78
  • 52 Week High
  • TWI $15.33
  • ALLO $5.78
  • Technical
  • Relative Strength Index (RSI)
  • TWI 44.71
  • ALLO 36.24
  • Support Level
  • TWI $7.49
  • ALLO $1.83
  • Resistance Level
  • TWI $8.05
  • ALLO $2.12
  • Average True Range (ATR)
  • TWI 0.65
  • ALLO 0.16
  • MACD
  • TWI -0.08
  • ALLO -0.02
  • Stochastic Oscillator
  • TWI 4.69
  • ALLO 12.16

About TWI Titan International Inc. (DE)

Titan International Inc is a manufacturer of wheels, tires, wheel and tire assemblies, and undercarriage systems and components for off-highway vehicles. The company operates through three segments namely Agricultural, Earthmoving/Construction, and Consumer. Geographically, business of the group can be seen in the United States, Europe / CIS, Latin America and Other international. Titan derives majority of the revenue from Agricultural segment which manufacture various agricultural equipment, including tractors, combines, plows, planters and irrigation equipment, and are sold directly to original equipment manufacturers and to the aftermarket through independent distributors, equipment dealers and Titan's own distribution centers.

About ALLO Allogene Therapeutics Inc.

Allogene Therapeutics Inc is a clinical-stage biotech firm specializing in immuno-oncology, focusing on the development of genetically engineered allogeneic T-cell products for cancer and autoimmune diseases. Their pipeline includes off-the-shelf T-cell candidates designed to target cancer cells or autoreactive cells in autoimmune disorders. Notably, their allogeneic approach, derived from healthy donors, allows for broader patient eligibility and scalability. With a vision to redefine CAR T therapy, the company concentrates on core programs targeting lymphoma, leukemia, autoimmune diseases, and solid tumors. Revenue, primarily generated from collaborations and licensing agreements, supports their research and development efforts.

Share on Social Networks: